Skip to main content

BC's change in methadone formulation: A metanarrative review of the literature

Date created
British Columbia’s Opioid Substitution Treatment (formerly Methadone Maintenance Therapy1 ) made a switch in formulation from generic methadone to a proprietary medication called Methadose™ (BC Ministry of Health, 2013) effective February 1 of 2014. The switch to Methadose™ in British Columbia (BC) offers an opportunity to examine the literature about methadone, MMT, and opioids and trace the evolution of policy and practice that inform this substitution therapy. A metanarrative review of the literature demonstrates the evolving perspective on MMT and offers insights to how a society views substance use, as well as future medication changes that affect a particular patient population, especially when that population is comprised of individuals who face structural inequities in mainstream Canadian society
Copyright statement
Copyright is held by the author(s).
Scholarly level
Peer reviewed?
Member of collection
Download file Size
Moreheart, Sarah - Capstone Paper.pdf 302.56 KB

Views & downloads - as of June 2023

Views: 42
Downloads: 2